Separating dopamine D


Journal

NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 01 10 2019
revised: 30 01 2020
accepted: 16 03 2020
pubmed: 24 3 2020
medline: 16 2 2021
entrez: 24 3 2020
Statut: ppublish

Résumé

Development of medications selective for dopamine D

Identifiants

pubmed: 32201327
pii: S1053-8119(20)30249-4
doi: 10.1016/j.neuroimage.2020.116762
pmc: PMC7263955
mid: NIHMS1579954
pii:
doi:

Substances chimiques

Carbon Radioisotopes 0
Dopamine Antagonists 0
Radiopharmaceuticals 0
Receptors, Dopamine D2 0
Receptors, Dopamine D3 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

116762

Subventions

Organisme : NIAAA NIH HHS
ID : K01 AA024788
Pays : United States
Organisme : NIDA NIH HHS
ID : K01 DA042998
Pays : United States
Organisme : NIDA NIH HHS
ID : R03 DA047588
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Références

Arch Neurol. 2007 Nov;64(11):1575-9
pubmed: 17998440
J Cereb Blood Flow Metab. 2002 Dec;22(12):1440-52
pubmed: 12468889
Drug Alcohol Depend. 2015 Sep 1;154:167-73
pubmed: 26164205
Psychopharmacology (Berl). 2016 Oct;233(19-20):3503-12
pubmed: 27525990
J Cereb Blood Flow Metab. 2001 Sep;21(9):1034-57
pubmed: 11524609
Nature. 1997 Apr 24;386(6627):830-3
pubmed: 9126741
Schizophr Res. 2011 Sep;131(1-3):63-8
pubmed: 21684721
J Cereb Blood Flow Metab. 2017 Mar;37(3):1095-1107
pubmed: 27207170
Neuroimage. 2011 Jan 1;54(1):264-77
pubmed: 20600980
Neuropsychopharmacology. 2014 Jan;39(2):311-8
pubmed: 23921256
Neuroimage. 2004 Jul;22(3):1214-22
pubmed: 15219593
Neuropsychopharmacology. 1999 Jan;20(1):60-80
pubmed: 9885786
Neuroimage. 2017 Mar 1;148:343-351
pubmed: 28110088
Neuroscience. 1999 May;90(2):433-45
pubmed: 10215149
Eur Neuropsychopharmacol. 2015 Sep;25(9):1410-20
pubmed: 26141509
Hum Brain Mapp. 2016 Mar;37(3):942-53
pubmed: 26703938
Schizophr Res. 2015 Oct;168(1-2):373-6
pubmed: 26190300
J Neurosci. 2012 Jan 25;32(4):1353-9
pubmed: 22279219
Biol Psychiatry. 2006 Mar 1;59(5):389-94
pubmed: 16373068
Hum Brain Mapp. 2007 Nov;28(11):1251-66
pubmed: 17274023
Neuroreport. 2005 Feb 8;16(2):175-8
pubmed: 15671872
J Med Chem. 2005 Jun 16;48(12):4153-60
pubmed: 15943487
J Neurosci. 1996 Oct 1;16(19):6100-6
pubmed: 8815892
Front Syst Neurosci. 2011 Feb 04;5:2
pubmed: 21442040
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Neuropsychopharmacology. 2016 Jan;41(2):529-37
pubmed: 26089182
Int J Neuropsychopharmacol. 2010 Apr;13(3):273-87
pubmed: 19751545
Arch Gen Psychiatry. 2009 Jun;66(6):606-15
pubmed: 19487625
Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1369-1382
pubmed: 30919054
Brain Connect. 2012;2(5):275-83
pubmed: 23025619
Neuropsychopharmacology. 2019 Jun;44(7):1284-1290
pubmed: 30659274
Neuropsychopharmacology. 2004 Jun;29(6):1190-202
pubmed: 15010698
Neuroimage. 2013 Mar;68:119-32
pubmed: 23207573
Eur J Neurosci. 2017 Jan;45(1):2-19
pubmed: 27600596
Brain. 2009 May;132(Pt 5):1366-75
pubmed: 19153147
Synapse. 2006 Dec 1;60(7):485-95
pubmed: 16952157
Psychol Bull. 1979 Mar;86(2):420-8
pubmed: 18839484
Int J Neuropsychopharmacol. 2018 Jun 1;21(6):522-527
pubmed: 29346639
Am J Psychiatry. 1990 Jun;147(6):719-24
pubmed: 2343913
J Nucl Med. 2014 Jun;55(6):960-6
pubmed: 24732151
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11271-5
pubmed: 7972046
Neuropsychopharmacology. 2004 Aug;29(8):1479-87
pubmed: 15100700
Neuropsychopharmacology. 2013 Jan;38(2):302-12
pubmed: 22968817
Neurology. 2016 Jan 19;86(3):224-30
pubmed: 26718579
Synapse. 2009 Sep;63(9):782-93
pubmed: 19489048
Hum Brain Mapp. 2001 Nov;14(3):140-51
pubmed: 11559959
Neuroimage. 2005 Jul 1;26(3):839-51
pubmed: 15955494

Auteurs

Kelly Smart (K)

Yale PET Center, Yale School of Medicine, New Haven, CT, USA.

Jean-Dominique Gallezot (JD)

Yale PET Center, Yale School of Medicine, New Haven, CT, USA.

Nabeel Nabulsi (N)

Yale PET Center, Yale School of Medicine, New Haven, CT, USA.

David Labaree (D)

Yale PET Center, Yale School of Medicine, New Haven, CT, USA.

Ming-Qiang Zheng (MQ)

Yale PET Center, Yale School of Medicine, New Haven, CT, USA.

Yiyun Huang (Y)

Yale PET Center, Yale School of Medicine, New Haven, CT, USA.

Richard E Carson (RE)

Yale PET Center, Yale School of Medicine, New Haven, CT, USA.

Ansel T Hillmer (AT)

Yale PET Center, Yale School of Medicine, New Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA. Electronic address: ansel.hillmer@yale.edu.

Patrick D Worhunsky (PD)

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA. Electronic address: patrick.worhunsky@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH